Additionally, PCa tumors that overexpressed CD117 and CD34, a transmembrane glycoprotein ubiquitously used as an hematopoietic cells marker, were also found to be more aggressive and to correspond to a more advanced stage of the disease (Foroozan et al., 2017). The gene discussed is CD34; the disease is posterior cortical atrophy.